• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期感染的 HIV-1 病毒导致其在法国境内扩散,且最近出现了频率增加的趋势。

Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency.

机构信息

Université Paris-Descartes, Equipe d'accueil 3620, Sorbonne Paris Cité, Paris, France.

出版信息

PLoS One. 2012;7(2):e31695. doi: 10.1371/journal.pone.0031695. Epub 2012 Feb 14.

DOI:10.1371/journal.pone.0031695
PMID:22348121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279407/
Abstract

OBJECTIVE

To analyse the contribution of primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) to the French viral epidemic.

METHODS

HIV-1 pol sequences included 987 PHI from the French ANRS PRIMO cohort between 1999 and 2010 and were analysed using a population-based phylogenetic approach. Clinical features, risk factors, sexual behaviour and drug resistance for clustered and nonclustered transmission events were ascertained.

RESULTS

Viruses from 125 (12.7%) of PHI cosegregated into 56 transmission chains, with increasing frequency during the last years (10.2% before 2006 versus 15.2% of clusters in 2006-2010, p = 0.02). The mean number of patients per cluster was 2.44. Compared to unique PHI, clusters involved more often men, infected through homosexual intercourse, of young age, with a high number of casual sexual partnerships and frequent previous HIV serological tests. Resistant strains were found in 16.0% and 11.1% of clusters and unique PHI, respectively (p = 0.11). Overall, 34% (n = 9) clusters included patients followed in French regions far apart, involving 13 clusters with at least one Parisian patient.

CONCLUSIONS

PHIs are a significant source of onward transmission, especially in the MSM population. Recently infected people contribute to the spread of the viral epidemic throughout the French territory. Survey of transmitted drug resistance and behavioural characteristics of patients involved into clustered PHI may help to guide prevention and treatment interventions.

摘要

目的

分析原发性人类免疫缺陷病毒 1 型(HIV-1)感染(PHI)对法国病毒流行的贡献。

方法

在 1999 年至 2010 年间,法国 ANRS PRIMO 队列中的 987 例 PHI 的 HIV-1 pol 序列,采用基于人群的系统进化分析方法进行分析。确定聚类和非聚类传播事件的临床特征、危险因素、性行为和耐药性。

结果

125 例(12.7%)PHI 的病毒聚集成 56 个传播链,在最近几年的频率增加(2006 年前为 10.2%,2006-2010 年为 15.2%,p=0.02)。每个聚类的平均患者数为 2.44。与独特的 PHI 相比,聚类更常涉及男性、同性恋、年轻、有较多的偶然性行为伴侣和频繁的先前 HIV 血清学检测。16.0%和 11.1%的聚类和独特 PHI 分别发现耐药株(p=0.11)。总体而言,34%(n=9)的聚类包括来自法国不同地区的患者,其中 13 个聚类至少有一个巴黎患者。

结论

PHI 是传播的重要来源,特别是在男男性行为者(MSM)人群中。最近感染的人有助于病毒在法国全境的传播。对参与聚类 PHI 的患者进行传播耐药性和行为特征调查,可能有助于指导预防和治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2702/3279407/5cba5d25398d/pone.0031695.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2702/3279407/5cba5d25398d/pone.0031695.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2702/3279407/5cba5d25398d/pone.0031695.g001.jpg

相似文献

1
Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency.近期感染的 HIV-1 病毒导致其在法国境内扩散,且最近出现了频率增加的趋势。
PLoS One. 2012;7(2):e31695. doi: 10.1371/journal.pone.0031695. Epub 2012 Feb 14.
2
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.1999 - 2014年法国HIV - 1传播的时空动态及针对性预防策略的影响
Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186/s12977-017-0339-4.
3
High rates of forward transmission events after acute/early HIV-1 infection.急性/早期HIV-1感染后较高的病毒传播率。
J Infect Dis. 2007 Apr 1;195(7):951-9. doi: 10.1086/512088. Epub 2007 Feb 16.
4
Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men.一项针对全州范围内HIV-1疫情的系统发育研究揭示了男男性行为者中持续且活跃的传播网络。
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):428-35. doi: 10.1097/QAI.0000000000000786.
5
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.2001 - 2002年法国全国性哨点调查:HIV - 1初治感染患者及未接受过抗逆转录病毒治疗的慢性感染患者的抗逆转录病毒药物耐药性
J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):545-52. doi: 10.1097/01.qai.0000155201.51232.2e.
6
Population-based HIV-1 incidence in France, 2003-08: a modelling analysis.基于人群的法国 HIV-1 发病率,2003-2008 年:建模分析。
Lancet Infect Dis. 2010 Oct;10(10):682-7. doi: 10.1016/S1473-3099(10)70167-5. Epub 2010 Sep 9.
7
Transmission networks of drug resistance acquired in primary/early stage HIV infection.在原发性/早期HIV感染中获得的耐药性传播网络。
AIDS. 2008 Nov 30;22(18):2509-15. doi: 10.1097/QAD.0b013e3283121c90.
8
Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort.简短通讯:1997年至2007年在法国感染的患者中存在HIV-1复合群和第二代重组毒株的证据:法国国家艾滋病研究机构(ANRS)CO06 PRIMO队列研究
AIDS Res Hum Retroviruses. 2010 Jun;26(6):645-51. doi: 10.1089/aid.2009.0201.
9
New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study.1996年至2006年法国初发感染患者中的新旧复杂重组HIV-1毒株:法国国家艾滋病研究机构(ANRS)CO06初发队列研究
Retrovirology. 2008 Aug 1;5:69. doi: 10.1186/1742-4690-5-69.
10
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?2014 年至 2016 年法国 HIV-1 原发性感染监测:耐药性趋于稳定,但多样性、聚类和毒力更高?
J Antimicrob Chemother. 2020 Jan 1;75(1):183-193. doi: 10.1093/jac/dkz404.

引用本文的文献

1
Low CD4 count was characterized in recent HIV CRF01_AE infection and it rapidly increased to reach a peak in the first year since ART initiation.低CD4细胞计数是近期HIV CRF01_AE感染的特征,并且在开始抗逆转录病毒治疗后的第一年迅速上升至峰值。
BMC Infect Dis. 2025 Mar 31;25(1):443. doi: 10.1186/s12879-025-10799-5.
2
Acute HIV-1 Infection: Paradigm and Singularity.急性人类免疫缺陷病毒1型感染:范例与独特性
Viruses. 2025 Mar 3;17(3):366. doi: 10.3390/v17030366.
3
Go Where the Virus Is: An HIV Micro-epidemic Control Approach to Stop HIV Transmission.

本文引用的文献

1
X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI.在原发性 HIV-1 感染时检测到的 X4 嗜性多药耐药准种在接近 PHI 时仍然是排他性的,或者至少是主要的。
PLoS One. 2011;6(8):e23301. doi: 10.1371/journal.pone.0023301. Epub 2011 Aug 24.
2
Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec.传播聚类驱动了魁北克男男性行为人群中 HIV 疫情的持续蔓延。
J Infect Dis. 2011 Oct 1;204(7):1115-9. doi: 10.1093/infdis/jir468.
3
Population-based HIV-1 incidence in France, 2003-08: a modelling analysis.
去病毒所在之处:一种控制艾滋病毒微流行以阻止艾滋病毒传播的方法。
Glob Health Sci Pract. 2020 Dec 23;8(4):614-625. doi: 10.9745/GHSP-D-19-00418.
4
Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain.属于传播链的 HIV-1 包膜糖蛋白的常见进化特征。
Sci Rep. 2020 Oct 7;10(1):16744. doi: 10.1038/s41598-020-73975-4.
5
Projected effectiveness of HIV detection during early infection and rapid ART initiation among MSM and transgender women in Peru: A modeling study.秘鲁男男性行为者和变性女性中早期感染时HIV检测及快速启动抗逆转录病毒治疗的预期效果:一项建模研究。
Infect Dis Model. 2019 Apr 6;4:73-82. doi: 10.1016/j.idm.2019.04.001. eCollection 2019.
6
Diverse Large HIV-1 Non-subtype B Clusters Are Spreading Among Men Who Have Sex With Men in Spain.多种大型HIV-1非B亚型集群正在西班牙男男性行为者中传播。
Front Microbiol. 2019 Apr 3;10:655. doi: 10.3389/fmicb.2019.00655. eCollection 2019.
7
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and Quebec.对高危人群进行深入抽样,以描述在法国和魁北克使用暴露前预防(PrEP)的年轻男男性行为者中的艾滋病毒传播流行情况。
Open Forum Infect Dis. 2019 Feb 15;6(3):ofz080. doi: 10.1093/ofid/ofz080. eCollection 2019 Mar.
8
Transmission patterns of HIV-1 non-R5 strains in Poland.波兰 HIV-1 非 R5 株的传播模式。
Sci Rep. 2019 Mar 21;9(1):4970. doi: 10.1038/s41598-019-41407-7.
9
Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France.揭示 HIV 发病率、未确诊 HIV 流行率和诊断时间的地理和人群异质性,以改善预防和护理:法国的估计。
J Int AIDS Soc. 2018 Mar;21(3):e25100. doi: 10.1002/jia2.25100.
10
Genetic Cluster Analysis for HIV Prevention.艾滋病预防的遗传聚类分析。
Curr HIV/AIDS Rep. 2018 Apr;15(2):182-189. doi: 10.1007/s11904-018-0384-1.
基于人群的法国 HIV-1 发病率,2003-2008 年:建模分析。
Lancet Infect Dis. 2010 Oct;10(10):682-7. doi: 10.1016/S1473-3099(10)70167-5. Epub 2010 Sep 9.
4
HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men.男性同性恋者停止早期抗逆转录病毒治疗后的 HIV-1 传播。
AIDS. 2010 May 15;24(8):1177-83. doi: 10.1097/QAD.0b013e328338e4de.
5
Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.尽管具有高度多样性,但免疫病毒学状态与原发性 HIV-1 感染期间的临床症状密切相关:这是一项基于 674 名参与 ANRS CO 06 PRIMO 队列的患者的横断面研究。
J Antimicrob Chemother. 2010 Apr;65(4):741-8. doi: 10.1093/jac/dkq035. Epub 2010 Feb 18.
6
Transmission networks of HIV-1 among men having sex with men in the Netherlands.荷兰男男性行为人群中 HIV-1 的传播网络。
AIDS. 2010 Jan 16;24(2):271-82. doi: 10.1097/QAD.0b013e328333ddee.
7
HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.近期血清转化者中1型人类免疫缺陷病毒的传播动态:与耐药性传播及病毒多样性的关系
Antivir Ther. 2009;14(4):551-6.
8
The global epidemic of HIV infection among men who have sex with men.男男性行为者中艾滋病毒感染的全球流行情况。
Curr Opin HIV AIDS. 2009 Jul;4(4):300-7. doi: 10.1097/COH.0b013e32832c3bb3.
9
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.传播集群对新诊断的HIV-1感染原发性耐药性的影响。
AIDS. 2009 Jul 17;23(11):1415-23. doi: 10.1097/QAD.0b013e32832d40ad.
10
Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005.1996 - 2005年,北美、西欧和澳大利亚男男性行为者中HIV疫情再度出现。
Ann Epidemiol. 2009 Jun;19(6):423-31. doi: 10.1016/j.annepidem.2009.03.004.